Tarazosin (Mylan Institutional Inc.)
Welcome to the PulseAid listing for the Tarazosin drug offered from Mylan Institutional Inc.. This Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Institutional Inc. |
| NON-PROPRIETARY NAME: | tarazosin |
| SUBSTANCE NAME: | TERAZOSIN HYDROCHLORIDE ANHYDROUS |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2000-04-01 |
| END MARKETING DATE: | 0000-00-00 |
Tarazosin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tarazosin from Mylan Institutional Inc. |
| LABELER NAME: | Mylan Institutional Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/1) |
| START MARKETING DATE: | 2000-04-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51079-936_9936832f-270a-475a-8707-0980c06136e0 |
| PRODUCT NDC: | 51079-936 |
| APPLICATION NUMBER: | ANDA075140 |
Other TERAZOSIN HYDROCHLORIDE ANHYDROUS Pharmaceutical Manufacturers / Labelers:
